Regnum Corp
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C"C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.
Regnum Corp (RGMP) - Net Assets
Latest net assets as of March 2023: $-1.35 Million USD
Based on the latest financial reports, Regnum Corp (RGMP) has net assets worth $-1.35 Million USD as of March 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($496.09K) and total liabilities ($1.85 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.35 Million |
| % of Total Assets | -272.36% |
| Annual Growth Rate | N/A |
| 5-Year Change | -2734.38% |
| 10-Year Change | N/A |
| Growth Volatility | 418.82 |
Regnum Corp - Net Assets Trend (2017–2022)
This chart illustrates how Regnum Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Regnum Corp (2017–2022)
The table below shows the annual net assets of Regnum Corp from 2017 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-1.16 Million | -205.59% |
| 2021-12-31 | $-379.82K | -653.72% |
| 2020-12-31 | $-50.39K | -756.16% |
| 2019-12-31 | $7.68K | -82.57% |
| 2018-12-31 | $44.06K | +250.74% |
| 2017-12-31 | $12.56K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Regnum Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 120138500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $22.95K | % |
| Other Components | $18.55K | % |
| Total Equity | $-1.16 Million | 100.00% |
Regnum Corp Competitors by Market Cap
The table below lists competitors of Regnum Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VioQuest Pharmaceuticals Inc
PINK:VOQP
|
$27.05 |
|
TANTALIZERS PLC
XNSA:TANTALIZER
|
$27.09 |
|
TRIPPLE GEE AND COMPANY PLC
XNSA:TRIPPLEG
|
$27.14 |
|
US Solar Fund PLC
LSE:USFP
|
$27.33 |
|
MUTUAL BENEFITS ASSURANCE PLC
XNSA:MBENEFIT
|
$26.72 |
|
REAL ESTATE INVESTMENTS ZAMBIA PLC
LUSE:REIZUSD
|
$26.42 |
|
Manila Bulletin Publishing Corp
PSE:MB
|
$26.35 |
|
Hai Jia International Limited Company
PINK:HBIE
|
$26.26 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Regnum Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -379,823 to -1,160,710, a change of -780,887.
- Net loss of 780,887 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-780.89K | -67.28% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Regnum Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $-0.02 | $0.00 | x |
| 2022-12-31 | $-0.05 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Regnum Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-65.45%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-742.50 |
| 2017 | 11.04% | 7.66% | 1.23x | 1.17x | $130.80 |
| 2018 | 4.53% | 9.34% | 0.45x | 1.08x | $-2.41K |
| 2019 | -473.70% | -577.46% | 0.74x | 1.10x | $-37.15K |
| 2020 | 0.00% | -1307.48% | 2.00x | 0.00x | $-112.63K |
| 2021 | 0.00% | -3000.00% | 0.01x | 0.00x | $-232.02K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-664.82K |
Industry Comparison
This section compares Regnum Corp's net assets metrics with peer companies in the Entertainment industry.
Industry Context
- Industry: Entertainment
- Average net assets among peers: $265,814,216
- Average return on equity (ROE) among peers: -33.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Regnum Corp (RGMP) | $-1.35 Million | 0.00% | N/A | $26.99 |
| AB International Group Corp (ABQQ) | $-6.78K | 0.00% | 0.00x | $405.91 |
| AI Era Corp. (ABQQD) | $4.02 Million | -54.05% | 0.45x | $87.52K |
| Color Star Technology Co. Ltd. (ADD) | $6.59 Million | -176.41% | 0.08x | $63.13K |
| Alliance Entertainment Holding Corporation Class A Common Stock (AENT) | $108.93 Million | 26.27% | 3.34x | $22.03 Million |
| All For One Media Corp (AFOM) | $-17.59 Million | 0.00% | 0.00x | $324.00 |
| Allied Gaming & Entertainment Inc. (AGAE) | $33.41 Million | -134.88% | 0.85x | $4.97 Million |
| AMC Entertainment Holdings Inc (AMC) | $1.51 Billion | 24.17% | 2.35x | $567.86 Million |
| AMC Networks Inc (AMCX) | $1.01 Billion | 8.82% | 2.88x | $212.42 Million |
| American Films Inc (AMFL) | $2.16 Million | -24.68% | 1.32x | $753.71 |
| Amcomri Entertainment Inc (AMNNF) | $-586.53K | 0.00% | 0.00x | $6.48K |